Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ichiro Inoue

Showing results (471-480 of 526) with videos related to

Pageof 53
Sort By:
Immunity|September 19, 2008
The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-toleranceTaishin Akiyama, Yusuke Shimo, Hiromi Yanai, et al.
Nature|March 13, 2012
The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory responseTakahito Sanada, Minsoo Kim, Hitomi Mimuro, et al.
Physical Review Letters|November 5, 2023
Femtosecond Reduction of Atomic Scattering Factors Triggered by Intense X-Ray PulseIchiro Inoue, Jumpei Yamada, Konrad J Kapcia, et al.
Scientific Reports|June 11, 2020
EXOSC9 depletion attenuates P-body formation, stress resistance, and tumorigenicity of cancer cellsSeiko Yoshino, Yusuke Matsui, Yuya Fukui, et al.
Developmental Cell|December 14, 2002
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclastsHiroshi Takayanagi, Sunhwa Kim, Takako Koga, et al.
The Journal of Experimental Medicine|November 12, 2014
Limitation of immune tolerance-inducing thymic epithelial cell development by Spi-B-mediated negative feedback regulationNobuko Akiyama, Miho Shinzawa, Maki Miyauchi, et al.
Viruses|June 14, 2020
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent MannerMizuki Yamamoto, Maki Kiso, Yuko Sakai-Tagawa, et al.
The Journal of Biological Chemistry|August 11, 2016
Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor κB (RANK) Signaling Complex Enhances OsteoclastogenesisJiyeon Yu, Hyeongseok Yun, Bongjin Shin, et al.
Chemical Biology & Drug Design|December 9, 2021
Development of chimeric receptor activator of nuclear factor-kappa B with glutathione S-transferase in the extracellular domain: Artificial switch in a membrane receptorKanako Kawashima, Mayuko Hirota-Tsukimachi, Tsugumasa Toma, et al.
Plos One|May 3, 2014
Mitochondria-nucleus shuttling FK506-binding protein 51 interacts with TRAF proteins and facilitates the RIG-I-like receptor-mediated expression of type I IFNTaishin Akiyama, Takuma Shiraishi, Junwen Qin, et al.
Pageof 53

Showing results (471-480 of 526) with videos related to

Sort By:
Pageof 53
Immunity|September 19, 2008
The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-toleranceTaishin Akiyama, Yusuke Shimo, Hiromi Yanai, et al.
Nature|March 13, 2012
The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory responseTakahito Sanada, Minsoo Kim, Hitomi Mimuro, et al.
Physical Review Letters|November 5, 2023
Femtosecond Reduction of Atomic Scattering Factors Triggered by Intense X-Ray PulseIchiro Inoue, Jumpei Yamada, Konrad J Kapcia, et al.
Scientific Reports|June 11, 2020
EXOSC9 depletion attenuates P-body formation, stress resistance, and tumorigenicity of cancer cellsSeiko Yoshino, Yusuke Matsui, Yuya Fukui, et al.
Developmental Cell|December 14, 2002
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclastsHiroshi Takayanagi, Sunhwa Kim, Takako Koga, et al.
The Journal of Experimental Medicine|November 12, 2014
Limitation of immune tolerance-inducing thymic epithelial cell development by Spi-B-mediated negative feedback regulationNobuko Akiyama, Miho Shinzawa, Maki Miyauchi, et al.
Viruses|June 14, 2020
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent MannerMizuki Yamamoto, Maki Kiso, Yuko Sakai-Tagawa, et al.
The Journal of Biological Chemistry|August 11, 2016
Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor κB (RANK) Signaling Complex Enhances OsteoclastogenesisJiyeon Yu, Hyeongseok Yun, Bongjin Shin, et al.
Chemical Biology & Drug Design|December 9, 2021
Development of chimeric receptor activator of nuclear factor-kappa B with glutathione S-transferase in the extracellular domain: Artificial switch in a membrane receptorKanako Kawashima, Mayuko Hirota-Tsukimachi, Tsugumasa Toma, et al.
Plos One|May 3, 2014
Mitochondria-nucleus shuttling FK506-binding protein 51 interacts with TRAF proteins and facilitates the RIG-I-like receptor-mediated expression of type I IFNTaishin Akiyama, Takuma Shiraishi, Junwen Qin, et al.
Pageof 53